Kenox Pharmaceuticals, Inc is an emerging player in the biotechnology and pharmaceutical industries. Founded in 2018, the company specializes in innovative aerosol-based drug delivery for inhalation, nasal, eye, and other applications. Kenox Pharmaceuticals offers extensive expertise in orally inhaled and nasal drug product (OINDP) design, development, manufacturing, and testing, aiming to bring life-changing inhaled and intranasal therapies to the clinic faster and more efficiently. With a focus on partnering with pharmaceutical and biotechnology companies, Kenox Pharmaceuticals combines large-company know-how with small-company agility to ensure unparalleled project and customer focus. The company invites potential partners to reach out via email at [email protected] to learn more about their capabilities and discuss specific needs.
There is no investment information
No recent news or press coverage available for Kenox Pharmaceuticals, Inc.